Applied Genetic Technologies is a clinical-stage biotechnology company. The company’s focus is gene therapy through a nontoxic adeno-associated virus.The company also offers gene-therapy-related products such as promoters, expression cassettes, and capsids. AGTC's pipeline portfolio consists of products to cure X-linked retinoschisis (inherited retinal degeneration), achromatopsia (an inherited condition associated with visual acuity loss and extreme light sensitivity), X-linked retinitis pigmentosa (inherited condition causing blindness), and age-related macular degeneration.